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ABSTRACT
White adipose tissue (WAT) thermogenic activity may play a role in whole-body energy balance
and two of its main regulators are thought to be environmental temperature (Tenv) and exercise.
Low Tenv may increase uncoupling protein one (UCP1; the main biomarker of thermogenic
activity) in WAT to regulate body temperature. On the other hand, exercise may stimulate UCP1
in WAT, which is thought to alter body weight regulation. However, our understanding of the
roles (if any) of Tenv and exercise in WAT thermogenic activity remains incomplete. Our aim was to
examine the impacts of low Tenv and exercise on WAT thermogenic activity, which may alter
energy homeostasis and body weight regulation. We conducted a series of four experimental
studies, supported by two systematic reviews and meta-analyses. We found increased UCP1 mRNA
(p = 0.03; but not protein level) in human WAT biopsy samples collected during the cold part of
the year, a finding supported by a systematic review and meta-analysis (PROSPERO review
protocol: CRD42019120116). Additional clinical trials (NCT04037371; NCT04037410) using
Positron Emission Tomography/Computed Tomography (PET/CT) revealed no impact of low Tenv
on human WAT thermogenic activity (p > 0.05). Furthermore, we found no effects of exercise on
UCP1 mRNA or protein levels (p > 0.05) in WAT biopsy samples from a human randomized
controlled trial (Clinical trial: NCT04039685), a finding supported by systematic review and meta-
analytic data (PROSPERO review protocol: CRD42019120213). Taken together, the present experi-
mental and meta-analytic findings of UCP1 and SUVmax, demonstrate that cold and exercise may
play insignificant roles in human WAT thermogenic activity.
Abbreviations: WAT:White adipose tissue; Tenv: Environmental temperature; UCP1: Uncoupling
protein one; BAT: Brown adipose tissue; BMI:Body mass index; mRNA: Messenger ribonucleic acid;
RCT: Randomized controlled trial; WHR: Waist-to-hip ratio; PRISMA: Preferred Reporting Items for
Systematic Reviews and Meta-analyses; PET/CT: Positron Emission Tomography and Computed
Tomography; REE: Resting energy expenditure; 18F-FDG: F18 fludeoxyglucose; VO2peak:Peak oxy-
gen consumption; 1RM: One repetition maximum; SUVmax: Maximum standardized uptake value;
Std: Standardized mean difference
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White adipose tissue (WAT) thermogenic activity
may play a role in whole-body energy balance and
two of its main regulators are thought to be envir-
onmental temperature (Tenv) and exercise [1].
Uncoupling protein one (UCP1; the main biomar-
ker of thermogenic activity) was, originally, thought
to be expressed exclusively in brown adipose tissue
(BAT) [2]. Its expression in white adipocytes indi-
cates that WAT may be a thermogenically active
endocrine organ with the potential to exert BAT-
like functions with associated health benefits for
body weight regulation and obesity phenotype[1],
including reduced body mass index (BMI) [3], fat
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mass [4] and increased metabolic rate[5]. Some
evidence suggests that low Tenv (i.e. cold exposure)
increases the expression of UCP1 mRNA and pro-
tein in human subcutaneous WAT [6]. However,
subsequent studies failed to confirm a connection
of UCP1 [7] and WAT thermogenic activity [8]
with cold exposure. They also suggested that exer-
cise increases WAT thermogenic activity [9], per-
haps due to increased demand for oxidation during
exercise to maintain energy supply [10]. Yet, this is
mainly supported by animal research [11–15],
whereas human studies failed to confirm
a significant impact of exercise on UCP1 in WAT
[16–18]. Uncovering the impacts of low Tenv and
exercise on WAT thermogenic activity will shed
light on the potential contribution of this endocrine
organ on energy homeostasis and body weight reg-
ulation, with associated spill-over effects for obesity
treatment and metabolic pathologies.
Materials and methods
We conducted a series of six studies: two clinical
trials, one cross-sectional study, one randomized
controlled trial (RCT), and two systematic reviews
and meta-analyses. The experimental studies con-
formed to the standards set by the Declaration of
Helsinki and were approved by the Bioethics
Review Boards of the University of Thessaly,
Department of Exercise Science (protocol numbers
698/13-3-2013 & 1257/7-6-2017), University of
Wolverhampton (protocol number 92,944/13-
6-2013) and Biomedical Research Foundation
Academy of Athens (protocol numbers 7/16-
3-2017 and 35/26-3-2019).
Study 1 (Cross-sectional)
Written consent was obtained from 32 healthy (no
chronic disease and/or being under medication treat-
ment) nonsmoking and non-regularly exercisers adult
men [age: 36.06 ± 7.36 (years); BMI: 27.60 ± 4.63 (kg/
m2)]. Table 1 in the supplement [19] shows the parti-
cipant characteristics. Participants visited the labora-
tory once between 07:00 and 09:00 am and underwent
measurements for body height using a Seca
(Hamburg, Germany) stadiometer, body weight
using a precision scale (KERN & Sohn GmbH,
Version 5.3, Germany), waist-to-hip ratio (WHR)
using a tape measure and body composition using
a bioelectrical impedance body composition monitor
(Fresenius Medical Care AG & Co. KGaA D-61,346
Bad Hamburg, Germany). We also randomly col-
lected nutritional data (telephone diet recall) for two
weekdays and oneweekend day, within aweek period.
The data collection for diet was conducted by an
independent investigator who was blinded to the
aim of the study. To assess UCP1 mRNA/protein
expression of WAT cells, participants also underwent
a subcutaneous WAT biopsy, following standard
guidelines [20], while they were instructed to refrain
from exercise, alcohol, and passive smoking in 72-h
prior the biopsy procedure. Briefly, the subcutaneous
WAT samples were taken 5 cm to the left or right of
the navel via a surgical technique using a standardized
methodology [21]. All samples were collected between
June 2013 and May 2014.
Study 2 (Systematic Review and Meta-analysis)
We conducted two systematic reviews and meta-
analyses (PROSPERO review protocol: study 2
CRD42019120116; study 6 CRD42019120213) to
test the results of our experimental studies against
the state of the art.
Following the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA)
guidelines [22], we searched the PubMed central,
Embase, and Cochrane Library (trials) databases
from the date of their inception to 21 April 2020,
for both studies that evaluated the effect of Tenv
and/or cold exposure on UCP1 of human WAT
(study 2) and studies that evaluated the effect of
exercise on both human and animal UCP1 of
WAT (study 6). No date, participants’ health sta-
tus, language, or study design limits were applied.
The searching procedure, screening of the titles,
abstracts, and full texts for eligibility as well as the
selection of the included studies were conducted
independently by two investigators (PCD and LGI)
and any conflicts were resolved through discussion
with a third investigator (ADF). We also supple-
mented the electronic database searches with man-
ual searches for published studies in relevant
websites. We excluded reviews and magazine arti-
cles, but we included published conference pro-
ceedings. We also searched the reference lists of
the included studies to identify potential eligible
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studies. The PRISMA flowcharts can be found in
Figure 6 for the UCP1 and cold exposure systema-
tic review (study 2) and in Figure 7 for the UCP1
and exercise systematic review (study 6) in the
supplement [19]. Also, the searching algorithm
for both systematic reviews can be found in the
supplement [19].
Two independent investigators (PCD and LGI)
evaluated the risk of bias of the included studies in
both systematic reviews. Conflicts in the risk of
bias assessment were resolved by an independent
referee investigator (ADF). As all included studies
conducted in humans used an observational
design, we evaluated the risk of bias via the 13-
item of Research Triangle Institute item bank [23]
which is designed for observational studies and has
previously shown median inter-rater agreement of
75% [24] and 93.5% [25]. Regarding studies con-
ducted in animals, we evaluated the risk of bias of
the included studies via the Systematic Review
Centre for Laboratory Animal Experimentation
(SYRCLE) tool [26]. The description of grouping
the components of both the aforementioned risk
of bias tools can be found in the supplement [19].
Independent data extraction was performed by
two investigators (PCD and LGI) and conflicts
were resolved through consensus and supervision
by a third researcher (ADF). When necessary,
additional information was requested from the
journals and/or the study authors via e-mail. For
all studies, we extracted the author name(s), year
of publication, cold exposure status or physical
activity/exercise intervention, data either on the
participants’ number, age, sex, BMI, or on animal
species and diet status. Finally, we extracted the
main outcome of WAT UCP1 (i.e. means±stan-
dard deviations/standard error). The data extrac-
tion tables for both systematic reviews can be
found in the supplement [19].
We conducted continuous, inverse variance,
random-effect model meta-analysis via the
RevMan 5.3 software. We used means and stan-
dard deviations of UCP1 mRNA and protein
expressions of WAT, to test: (a) mean differences
between cold exposure and thermoneutral condi-
tions, either pre and post cold exposure or
between a cold and a warm period and (b) mean
differences between exercise and non-exercise,
either pre- and post-exercise or between exercise
and control (non-exercise) groups. The study
effect sizes were synthesized to account for hetero-
geneity due to differences in study populations,
interventions, study duration, and other factors.
We evaluated the 95% confidence interval (CI)
and heterogeneity between studies using the I2
statistic. We considered a statistically significant
result for heterogeneity when p < 0.10, while inter-
pretation of I2 index was made based on previous
guidelines [27]. Where pertinent, standard error
(SE) was converted to standard deviation (SD)
using the following formula: SD = SE*√n [27].
Study 3 (Clinical Trial)
We conducted a clinical trial (registration number:
NCT0403737), using Positron Emission
Tomography and Computed Tomography (PET/
CT) to assess the association of human subcuta-
neous WAT thermogenic activity with the Tenv,
using a cooling protocol.
Participants recruited through an advertisement
in local newspapers or by word of mouth. An initial
appointment was made to inform participants about
the study and determine eligibility. A health pre-
screening was done by interview through a suitable
medical history questionnaire. We obtained written
consent from 20 healthy (no chronic disease and/or
being under medication treatment) and nonsmoking
adult men [age: 36.30 ± 5.33 (y); BMI: 28.46 ± 5.49
(kg/m2)]. Table 4 in the supplement [19] displays
participants’ characteristics.
On the day of the measurement’s participants
advised to transport themselves by car to the PET/
CT Laboratory at 07:30 am, following at least a 12-
h fasting. At 8 am, the participants consumed
a meal consisted of 50% carbohydrates, 20% pro-
teins, and 30% fat to avoid a thermic effect of food
on BAT and WAT activity [28]. Also, to avoid
a thermic effect of food on the resting energy
expenditure (REE) measurements, the caloric
value of the meal was 15% of the total energy
requirements of each participant [29]. The total
energy requirement was calculated following the
previous methodology [30]. We have adopted the
above-mentioned approach to avoid extending
participants´ fasting hours, to control their diet
for at least 19 hours before the measurements
and to avoid a thermic effect of food on REE and
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WAT thermogenic activity. At 14:00 pm partici-
pants underwent measurements for body height
using a Seca (Hamburg, Germany) stadiometer,
body weight using a precision scale (KERN &
Sohn GmbH, Version 5.3, Germany) and WHR
using a tape measure. We also measured blood
pressure using a Standard Aneroid sphygmoman-
ometer (Medisave, UK) according to standard
guidelines [31]. Blood glucose levels were deter-
mined via a Contour NEXT/ASCENSIA monitor.
Participants who displayed blood glucose
>140 mg/dl and blood pressure >140 mm/Hg
were excluded from the study [32].
Immediately after the aforementioned measure-
ments, participants wore specific clothes (long-
sleeve sweatshirt and sweatpants) that offered
0.49 clo insulation [4]. Participants then under-
took an REE assessment. Following the REE mea-
surement, they remained in a sitting position in
a cold room at 16.7 ± 0.6°C (humidity:
49.0 ± 11.1%) for 2 h [4]. The room temperature
and humidity were continuously monitored, while
an investigator checked every 15 min participants’
muscle shivering status, according to previous
methodology [33]. The muscle shivering was
tested using a scale, none (no tension of muscles
reported), mild (slight muscle tonus in masseter
muscle), moderate (real shivering in proximal
muscles), severe (uncontrolled shivering in whole
body) [33]. In case of moderate or severe shiver-
ing, participants were covered with a blanket for
the next 15 minutes. The results of the muscle
shivering measurements can be found in Table 5
in the supplement [19]. After the first hour of cold
exposure, an appropriate dose – according to par-
ticipants’ body weight – of F18 fludeoxyglucose
(18F-FDG) (Table 4 in the supplement) [19] was
injected. Following the 2-h cooling protocol, par-
ticipants undertook the PET/CT examination.
A Siemens Biograph 6 high-resolution Erlangen
Germany (2006) PET/CT was used to obtain
images from the top of the skull to the upper
third of the thigh. Six to eight bed positions (5
min per bed position) were required.
PET/CT imaging analysis for BAT activity is
described elsewhere [3]. WAT activity analysis
(dorso-lumbar region near vertebrae L3 and abdom-
inal region) was performed by two independent
trained physicians (AG and SC), using previous
methodology [8]. A representative image can be
found in Figure 3 in the supplement [19]. Body
composition measurements, REE assessments, and
Tenv recording are described in the supplement [19].
Study 4 (Clinical Trial)
We have conducted a clinical trial (registration
number: NCT04037410), using PET/CT to assess
the association of human subcutaneous WAT
thermogenic activity with the Tenv, using a non-
cooling protocol. We retrospectively evaluated the
association of WAT thermogenic activity with Tenv
of 202 (male = 126) patients. Patients’ character-
istics can be found in Table 6 in the supplement
[19]. These patients undertook a PET/CT exami-
nation in order to define their disease status. They
were given instructions in advance to refrain from
smoking, exercise, and excessive muscle stressors
24-h prior to their examination. On the day of the
measurements, they were advised to transport
themselves by car to the PET/CT Laboratory
between 08:00 am to 12:00 pm, following at least
a 6-h fasting. Patients were first injected with an
appropriate dose of 18F-FDG (Table 6 in the sup-
plement) [19] and then they remained in a sitting
relaxed position in a quiet room of 22–24°C for
60 minutes. Following this period, patients under-
took the PET/CT examination, which included on
average eight bed positions, while 4-min scanning
per bed position was used. PET/CT imaging ana-
lysis for WAT activity analysis, body composition
measurements, REE assessments, and Tenv record-
ing was the same as study 3.
Study 5 (Clinical Randomized Control Trial)
To assess the effects of exercise on human WAT
thermogenic activity, we have conducted a parallel
RCT (clinical trial registration number:
NCT04039685) of an 8-wk of moderate-intensity
exercise training followed by an 8-wk of de-
training period. A priori power calculation was
conducted using an online software (DSS
Research) to test statistical power based on previous
data of UCP1mRNA [(baseline = 0.00010 ± 0.0003),
(post-exercise = 0.00020 ± 0.00005)] that were
reported in a similar controlled trial conducted in
humans [17]. The power calculation analysis
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showed a required sample size of at least seven
participants per group. This result ensured 100%
of statistical power (alpha error 5%). Participants
were recruited by advertisements in a local news-
paper in the area of Trikala, Thessaly, Greece; the
experimental protocol started in July 2013 and
ended in June 2014. Participants were asked to call
the researcher in charge (PCD) for an initial inter-
view in order to identify eligibility. The inclusion
criteria were: healthy adult men not participating in
a regular exercise program, nonsmoker, no chronic
disease, and/or being under medication treatment.
Information on the health status was retrieved
through a medical history questionnaire via inter-
view. Information on the physical activity levels was
retrieved via the International Physical Activity
Questionnaire [34]. Participants, who were healthy,
not participated in a regular exercise program and
displayed low or moderate physical activity levels
were eligible to participate in the study and they
were given a period of 7 d to decide their participa-
tion. Upon inclusion, a participant was randomly
assigned to a group using an online computer soft-
ware [35]. The initial allocation and enrollment of
the participants to an experimental group were
completed by the researcher in charge (PCD)
while the supervision of the exercise interventions
was completed by three assistant investigators, one
for each exercise group who were blinded to the aim
of the study. The selection process along with rea-
sons for exclusions as well as participant dropouts
in the RCT design appear in a Consolidated
Standards of Reporting Trials diagram in Figure 1
in the supplement [19].
The RCT involved four groups: an aerobic exer-
cise group, a resistance exercise group, a combined
exercise group (aerobic+resistance), and a non-
exercise control group. Measurements for anthropo-
metry, body composition, REE, and subcutaneous fat
biopsy were obtained at baseline, after the exercise
(wk 8) and the de-training (wk 16) periods while
physical activity (pedometer) and nutritional data
(diet recall) were randomly collected for two week-
days and one weekend day at baseline, 8th, and 16th
wk. The data collection for physical activity and diet
was conducted by an independent investigator who
was blinded to the aim of the study. Peak oxygen
consumption (VO2peak) and one-repetition maxi-
mum (1RM) were measured at baseline, 4th, 8th,
and 16th wk. The details of the experimental proto-
col are displayed in Figure 2 in the supplement [19].
The participants' characteristics, anthropometry,
assessment of physical activity and exercise pro-
grams, REE assessments, VO2peak and 1RM tests,
diet assessments, and mRNA and protein analyses
for this RCT are described in the supplement [19].
Study 6 (Systematic Review and Meta-analysis)
All methods regarding the systematic review pro-
cess and the meta-analysis are the same as
study 2.
Statistical analyses for experimental studies
All analyses were conducted with SPSS (v24; SPSS
Inc., Chicago, IL, USA) using a p ≤ 0.05 level of
significance. All variables were tested for normal
distribution using Kolmogorov–Smirnov. We used
Pearson Correlation coefficients or Spearman’s cor-
relation tests to evaluate the associations between
variables. Linear regression analysis was used to
calculate R2 and Cohen’s f2 effect size analysis
(f2 = R2/1-R2) was used to estimate effect sizes for
associations between variables. Independent sample
T-tests were used to examine mean differences in
UCP1 between cold and warm periods of the year
and Mann–Whitney U tests to examine mean dif-
ferences in SUVmax between cold and warm periods
of the year.
Given the non-normal distribution of the vari-
ables examined in the RCT (study 5), delta scores
were calculated and they were tested for normal
distribution using Kolmogorov–Smirnov. The delta
scores displayed normal distribution. The effects of
exercise and de-training on the delta scores of the
variables were tested using analyses of variance
(ANOVA) with Bonferroni post hoc t-tests.
Following the previous methodology, the 50th per-
centile of each variable was used to define the low
and high responders in order to test the effects of
exercise and de-training on the high responders [36].
Chi-square tests were used to assess differences
between the experimental groups and the variables
examined based on low and high responders’ status.
Kruskal–Wallis analysis of variance with post hoc
Mann–Witney U tests were used to assess the effects
of exercise and de-training of high responders on the
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variables examined. Pooled Cohen’s d effect size
analysis was used to calculate effect sizes between
and within groups using the following formula:
M1M2ð Þffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
N11ð Þ SD1ð Þ2þ N21ð Þ SD2ð Þ2
N1þN22
q (N = group sample size,
M = mean, SD = standard deviation) [37]. Finally,
Wilcoxon Signed Rank tests were used to calculate
differences within groups between time points given
the abnormal distribution of some variables.
Results
Subcutaneous WAT biopsies obtained from
healthy men (study 1) showed that the daily or
monthly Tenv in which they lived in was not asso-
ciated with UCP1 mRNA or protein expression
(p > 0.05, Cohen’s f2 < 0.20; representative images
and photographic films for UCP1 measurements
in the supplement) [19]. Also, we found no mean
differences (p > 0.05, Cohen’s dsmall = 0.43) in
UCP1 protein expression between a cold period
(1 Dec–31 Mar) and a warm period (1 Apr–30
Nov) of the days that the biopsies obtained, even
though UCP1 protein expression was higher in the
cold period (UCP1 mean: 1.25 ± 0.70, average
Tenv = 7.95 ± 2.23°C) than in the warm period
(UCP1 mean: 0.95 ± 0.68, average Tenv
= 22.61 ± 4.40°C). Nevertheless, the UCP1
mRNA expression was higher [t(30) = 2.23,
p = 0.03, Cohen’s d = 0.81, Figure 1] and BMI
had a tendency to be lower [t(30) = −1.25, p = 0.22,
Cohen’s d = 0.55] during the cold (Dec 1-Mar 31;
Tenv = 7.95 ± 2.23°C) versus the warm
(Apr 1-Nov 30; Tenv = 22.61 ± 4.40°C) periods of
the year (for the Northern hemisphere). However,
these differences in UCP1 mRNA expression
revealed no association with the differences in
BMI (p > 0.05). Furthermore, no mean differences
(p > 0.05) were found for UCP1 mRNA/protein
expression between the cold and the warm period
of the year within each BMI category (i.e. normal
BMI<25 kg/m2, UCP1 mRNA Cohen’s dsmall
= 0.49, UCP1 protein Cohen’s dsmall = 0.41; over-
weight BMI = 25.1–30 kg/m2, UCP1 mRNA
Cohen’s dmoderate = 0.55, UCP1 protein Cohen’s
dmoderate = 0.54; and obese BMI>30 kg/m
2, UCP1
mRNA Cohen’s dlarge = 1.39, UCP1 protein
Cohen’s d = 0.13). We also found that UCP1
mRNA/protein expression displayed no associa-
tions with percent fat mass and BMI (p > 0.05,
Cohen’s f2 < 0.20). These findings were not influ-
enced by diet (fat/carbohydrate/protein/caffeine
content, energy intake, total food mass were simi-
lar in the two periods of the year; p > 0.05); sug-
gesting that the influence of low Tenv during the
Figure 1. Mean differences in uncoupling protein one (UCP1) mRNA expression and protein concentrations between cold
(Dec 1-Mar 31) and warm (Apr 1-Nov 30) periods of the year (for the Northern hemisphere). *Significant differences. Values are
presented as means and standard deviations.
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cold period on UCP1 mRNA had an insignificant
impact on body weight regulation.
The finding from study 1 that low Tenv may play
an insignificant role in WAT UCP1 mRNA/pro-
tein and body weight regulation was evaluated
against the state-of-the-art through a systematic
review and meta-analysis (study 2). The search
process identified five published studies reporting
results for UCP1 mRNA but no studies reporting
results for UCP1 protein levels. Three of these
studies [6,7,38] together with data from study 1
provided data for a meta-analysis showing that low
Tenv increases UCP1 mRNA in human WAT
[standardized mean difference (Std) = 1.81, con-
fidence interval (CI) = 0.50 to 3.13, p = 0.007
(Figure 2)]. One of the eligible studies [6] and
study 1 provided data for a second meta-analysis
showing that low Tenv attenuates BMI [mean dif-
ference = −1.04, CI = −1.63 to −0.44, p = 0.0007
(see supplement)] [19]. These findings confirm
that low Tenv increases UCP1 mRNA in human
WAT, however with a questionable impact on
WAT thermogenic activity and body weight
regulation.
Thermogenic activity in WAT can be evaluated
using the maximum Standardized Uptake Values
(SUVmax) recorded during PET/CT scans [8]. In
a cohort of 20 healthy men (study 3), we found
a moderate inverse association between percent fat
mass (rho = −0.67, p = 0.001, Cohen’s f2moderate
= 0.69) and BMI (r = −0.71, p = 0.0001, Cohen’s f2
moderate = 0.75) with SUVmax in WAT (Figure 3),
indicating that WAT thermogenic activity may be
associated with a leaner phenotype. However,
there was no effect of either low Tenv or the cold
period (Tenv = 12.00 ± 4.57°C) of the year on the
SUVmax values recorded following a 2-h cooling
protocol (p > 0.05). Also, no mean differences
(p > 0.05) were found for SUVmax between the
cold and the warm period within each BMI cate-
gory (i.e. normal BMI<25 kg/m2, Cohen’s d = 0.01;
overweight BMI = 25.1–30 kg/m2, Cohen’s
d = 0.15; and obese BMI>30 kg/m2, Cohen’s
d = 0.01). These findings may be attributed to
the 2-h cooling protocol used prior to the PET/
CT scans. In our study, 11 out of the 20 partici-
pants were positive (SUVmax>1.5) in BAT activity,
suggesting that the increased SUVmax in BAT
caused by the 2-h cooling protocol adopted may
have masked a potentially small, yet significant,
impact of low Tenv on the SUVmax values recorded
in WAT. To test whether this masking effect
occur, we proceeded in a subsequent similar
PET/CT study without a cooling protocol.
In a cohort of 202 patients (study 4) who under-
took a PET/CT without a cooling protocol, we
found no effect of either low Tenv or the cold
period (Tenv = 8.66 ± 3.75°C) of the year on the
SUVmax values recorded and on BMI (p > 0.05;
Cohen’s d < 0.20). Confirming study 3 which used
a cooling protocol prior to the PET/CT, we found
a minor inverse association between BMI and
SUVmax in WAT (rho = −0.24, p = 0.001,
Cohen’s f2 < 0.20, Figure 4), indicating that WAT
thermogenic activity may be associated with
a leaner phenotype, similarly to BAT thermogenic
activity [1,3,4]. We found however, no mean dif-
ferences (p > 0.05) for SUVmax between the cold
and the warm period within each BMI category
(i.e. normal BMI<25 kg/m2, Cohen’s d = 0.06;
overweight BMI = 25.1–30 kg/m2, Cohen’s
d = 0.01; and obese BMI>30 kg/m2, Cohen’s
dsmall = 0.28). Taken together, studies 1 through
4 show that low Tenv may increase UCP1 mRNA
Figure 2. Forest plot of main effect of cold exposure on uncoupling protein 1 (UCP1) mRNA expression in subcutaneous human
white fat. SD: standard deviation; TWF: thigh white fat; AWF: abdominal white fat.
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in human WAT, however with an insignificant
impact on WAT thermogenic activity and body
weight regulation.
Regarding the impact of moderate-intensity
exercise on UCP1 mRNA and protein expression
in subcutaneous WAT biopsies obtained from
healthy men in a RCT (study 5), we found no
differences between and within groups in UCP1
mRNA or protein expressions neither between
baseline and post-exercise (wk 8) nor between
post-exercise (wk 8) and post-de-training (wk 16;
p > 0.05). Additional analyses of UCP1 mRNA and
protein expressions for low- (<50th percentile) and
high- (>50th percentile) responders to the moder-
ate-intensity exercise and to the de-training sti-
muli also showed no differences between the
experimental groups at all time points (p > 0.05).
From a clinical viewpoint, the 8-wk moderate-
intensity exercise interventions improved VO2
peak and 1RM, but had no effect on REE,
BMI, percent fat mass, fat-free mass, and dietary
habits (p > 0.05; see supplement) [19].
The finding from study 5 that exercise does not
impact WAT UCP1 mRNA and protein expressions
was evaluated against the state-of-the-art through
a systematic review and a series of meta-analyses
Figure 3. PET/CT cooling protocol study; associations of SUVmax-WAT-activity with %fat mass (a) and body mass index (b).
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(study 6). The search process identified eight eligi-
ble studies conducted in humans and 19 eligible
studies conducted in animals (see supplement)
[19]. Four of the studies in humans [16–18,39]
together with data from study 5 provided data for
a meta-analysis showing no effect of chronic exer-
cise on UCP1 mRNA (p > 0.05; no data were
available to test this hypothesis for UCP1 protein
expression). Seven of the studies in animals identi-
fied in the systematic review that used a normal diet
[11–15,40,41] provided data for a meta-analysis
showing no effect of chronic exercise on UCP1
mRNA (p > 0.05). An additional meta-analysis
using data from four studies [11,42–44] for UCP1
protein expression showed a significant impact of
chronic exercise in normal diet animals (Std = 0.41,
CI = −0.01–0.83, p = 0.05, Figure 5). With respect
to acute exercise (i.e. a single exercise bout) in
animals consuming a normal diet, a meta-analysis
using data from two eligible studies [45,46] revealed
a significant impact of exercise on UCP1 mRNA
(Std = 1.76, CI = 0.48–3.04, p = 0.007, Figure 6). In
animals consuming a high-fat diet, a meta-analysis
using data from four eligible studies [14,43,44,47]
showed significant impacts of chronic exercise on
both UCP1 mRNA (Std = 2.94, CI = 0.24–5.65,
p = 0.03, Figure 7) and protein (Std = 2.06,
CI = 0.07–4.05, p = 0.04, Figure 14 in the supple-
ment) [19] expression.
Discussion
In this series of four experimental and two meta-
analytic studies, we aimed to shed light on the
impacts of low Tenv and exercise on human
WAT thermogenic activity. Regarding the effects
Figure 4. PET/CT non-cooling protocol study; associations of SUVmax with body mass index.
Figure 5. Forest plot of main effect of chronic exercise on uncoupling protein 1 (UCP1) expression in white fat of normal diet
animals. SD: standard deviation; MIT: moderate-intensity training; HIIT: high-intensity interval training.
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of low Tenv on human UCP1 of subcutaneous
WAT, we found that cold exposure may be unable
to increase WAT thermogenic capacity (i.e. UCP1
levels) and consequently to alter energy homeos-
tasis and body weight regulation. This finding is
well supported by our meta-analysis of previous
evidence; however, there is a lack of evidence in
humans for UCP1 protein expression in WAT in
response to low Tenv.
Taken together, the available evidence for the
impact of exercise on WAT mRNA/protein
expression suggests distinct differences between
humans and animals. The findings in humans
demonstrate that exercise does not impact WAT
UCP1 mRNA and protein expressions. In contrast,
studies conducted in animals show that both
chronic and acute exercise increase UCP1 activa-
tion in WAT independently of the diet consumed.
These contradictory findings may be explained by
the heterogeneity (i.e. molecular signature) of
WAT depots and the challenge to isolate those
that exhibit brown-like properties in humans
[10]. Also, anatomical differences in both brown
and brown-like adipocytes were observed between
humans and animals [2,10]. Another reason could
be that obese animals displayed more UCP1 than
lean animals, the opposite trend of humans [48],
which indicates differences in UCP1 adaptations
to exercise between animals and humans.
Our approach in this series of studies has
a number of strengths. We used systematic reviews
and meta-analyses to test our findings from the
experimental studies, rather than selecting pre-
vious similar studies to elucidate our results. In
our studies 1 and 5, we analyzed UCP1 protein
expression in addition to UCP1 mRNA, so that we
test the actual stimulus of thermogenesis in WAT,
which entirely depends on the UCP1 protein [49].
In this regard, in study 5 we have tested the asso-
ciations between REE and UCP1 mRNA/protein
expressions at baseline, post-exercise, and post-
detraining. Results showed an inverse association
of REE with UCP1 protein expression
(rho = −0.36, p = 0.05, Cohen´s f2 = 0.15) post-
exercise. This finding does not support the
hypothesis that UCP1 may increase REE, which
could alter energy homeostasis. We used biopsies
to obtain the best available UCP1 evidence for
human subcutaneous WAT, while a PET/CT
approach allowed us to also obtain robust evidence
for the human WAT thermogenic activity.
Regarding the systematic review approach, we
used appropriate algorithms with standardized
indexing terms to search relevant to the aims of
Figure 6. Forest plot of main effect of acute exercise on uncoupling protein 1 (UCP1) mRNA expression in white fat of normal diet
animals. SD: standard deviation.
Figure 7. Forest plots of main effect of chronic exercise on uncoupling protein 1 (UCP1) expression in white fat of high-fat diet
animals. SD: standard deviation; HFD: high-fat diet; L-C: L-carnosine.
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the systematic review databases. Standardized
indexing terms can retrieve records that may use
different words to describe the same term beyond
that may be contained in the words of the title and
abstract [27]. Furthermore, our systematic reviews
used a robust methodology for systematic litera-
ture searching [50–52] while we used well-
established tools [23,26] to evaluate the quality of
the included studies. Also, to reduce bias two
investigators worked independently on the search-
ing, screening, inclusion of eligible studies, data
extraction, and risk of bias assessment. Finally,
we have not excluded studies based on language
and we considered conference proceeding to
expand our data collection pool.
Our studies are not without their limitations.
Regarding the actual exposure to low Tenv of our
participants in their everyday life, this was not
tested; for instance, the time the participants spent
in outdoor activities (e.g. work) and their clothing
insulation during a cold period of the year. From
a practical point of view however, these assessments
can be very challenging. Also, we only included
body temperature measurements in study 3, as
a precaution for the exposure of the participants
in the cold environment. Body temperature in study
3 showed no associations with SUVmax (p > 0.05).
The association of body temperature with UCP1
and SUVmax, however, was not tested in studies 1,
4, and 5. Regarding study 1, we were unable to
locate previous data to perform sample size calcula-
tion for UCP1 protein values. However, we per-
formed a post-measurement power calculation
using an online software (DSS Research) to test
statistical power based on previous similar data of
UCP1mRNA(mean±standarddeviation=6.59±2.4)
[6]. This analysis revealed 100% statistical power for
study 1. In our PET/CT studies (studies 3 and 4) we
were unable to perform either a pre or post-
measurements power calculation, given the absence
of relevant studies in the literature, since the only
similar study [8] used SUVmean as a measurement
value for WAT activity, which is different from our
PET/CT studies (SUVmax). In our PET/CT cooling
protocol study 3 we used only men, therefore, gen-
der differences could not be determined.
Furthermore, in our PET/CT non-cooling protocol
study 4 the measurements were performed only in
patients; however, patients have been previously
recruited in several studies related to 18F-FDG
BAT activity [3,53–55]. A limitation could be that
the exercise programs in our RCT study were based
on 65% intensity throughout the exercise period,
which may be relatively low intensity for biological
adaptations in healthy populations. However, the
exercise programs were effective in terms of VO2
peak and 1RM adaptations (see supplement) [19].
Regarding the systematic reviews, we found no
RCTs eligible studies conducted in humans, while
there was only one RCT among the eligible studies
that conducted in animals. This may have lowered
the strength of the available evidence used in our
meta-analyses. Furthermore, the heterogeneity of our
meta-analyses was relatively high, which implies
a variation in the studies used in each included
meta-analysis. In this regard, there was a small num-
ber of studies to be included in each meta-analysis
(2–5), which did not allow for funnel plot generation
to assess publication bias [27]. The overall risk of
bias in the studies used for the meta-analyses
included in study 2 was low or unclear, which sug-
gests interpreting the results of these meta-analyses
with relative confidence. However, the overall risk of
bias in the studies used for the meta-analyses
included in study 6, was high. As such, the results
of these meta-analyses should be interpreted with
caution.
Cold exposure may stimulate WAT to increase
UCP1 gene expression via sympathetic nervous
activation and norepinephrine stimulation [56].
This may cause a “browning” process of WAT
with the potential to exert BAT-like functions [1].
It is suggested, however, that “browning” of WAT
may also occur via chronic stimulation of β3 adre-
nergic agents [56]. There is also a possibility of
some “browning” agents to disrupt UCP1 expres-
sion in WAT [56], which may lead to low UCP1
detection in the tissue. This implies that the pre-
sence or absence of these pathways may have
affected the UCP1 gene expression and the thermo-
genic activity of WAT in our participants.
Therefore, the fact that we were unable to examine
these pathways may pose a limitation in our studies.
In conclusion, the findings presented in this
series of six studies improve our understanding
of white-fat thermogenesis. Taken together, the
present experimental and meta-analytic findings
of UCP1 and SUVmax, demonstrate that cold and
TEMPERATURE 49
exercise may play insignificant roles in human
WAT thermogenic activity. As such, the role of
human WAT thermogenesis in energy homeosta-
sis and body weight regulation (if any) remains
under investigation. Although our findings on
UCP1 and SUVmax are complemented by nutri-
tional and body measurements, other factors such
as environmental temperatures out of the range
tested in our study may play a role in human
WAT thermogenic capacity and should be
explored in future studies.
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